[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-245054-105":53,"doc-detail-245054-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","gantt-chart-example-bpn-biologics","Gantt-chart-example-BPN-Biologics","","This document provides an example Gantt chart for BPN Biologics applications. It is intended for illustrative purposes only and does not constitute an endorsement of specific activities, development plans, or formats. The Gantt chart is a mandatory attachment for BPN Biologics applications, requiring a project timeline that details key activities for each year of grant funding and explicitly identifies the entity responsible for each activity. The provided example outlines a project spanning five years, divided into Phase I and Phase II, with detailed research activities such as lead optimization, PK studies, in vivo efficacy testing, pre-IND preparations, CMC activities, GLP safety pharmacology, and IND submission. The chart also indicates co-funding by NIH CRO and PI-led sub-awards. This template emphasizes the importance of clear project planning and transparent reporting in grant applications.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/gantt-chart-example-bpn-biologics/245054/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/gantt-chart-example-bpn-biologics/245054.png","ImageObject",442,249,{"name":88,"@type":89},"8796093062539","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-09-20","2026-09-12",true,{"@type":98,"interactionType":99,"userInteractionCount":76},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the purpose of the provided Gantt chart example?","Question",{"text":108,"@type":109},"The Gantt chart example is for illustrative purposes, demonstrating the required format for BPN Biologics applications, and is not an endorsement of specific activities or plans.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What information must be included in a Gantt chart attached to BPN Biologics applications?",{"text":113,"@type":109},"Gantt charts must include a project timeline showing key activities for each year of grant funding and clearly indicate who will conduct each activity.",{"name":115,"@type":106,"acceptedAnswer":116},"What are the main phases and activities detailed in the sample Gantt chart?",{"text":117,"@type":109},"The sample chart outlines Phase I and Phase II activities over five years, including lead optimization, PK studies, in vivo efficacy, pre-IND preparation, CMC, safety pharmacology, and IND submission.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},245054,1789224711,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":60,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":129,"file_id":130,"file_url":131,"file_type":132,"file_size":133,"view_count":76,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":9,"language":134,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":135,"faqs":136,"seo_title":137,"seo_description":61,"update_tm":125,"read_time":4},8796093062539,"Sample BPN Biologics Gantt Chart  \nThe example Gantt chart is for illustrative purposes only. BPN Biologics is not endorsing particular activities , development plans, or formats. Gantt charts, which are required as attachments in BPN Biologics applications, are expected to include a project timeline that shows key activities for each year of grant funding and clearly indicates who will conduct each activity.  \n\n| UG3 or U44 Phase I |  | UH3 or U44 Phase II |  |  |\n| --- | --- | --- | --- | --- |\n| Year 1\u003Cbr>Aim Research activity Q1 Q2 Q3 Q4 | Year 2\u003Cbr>Q1 Q2 Q3 Q4 | Year 3\u003Cbr>Q1 Q2 Q3 Q4 | Year 4\u003Cbr>Q1 Q2 Q3 Q4 | Year 5\u003Cbr>Q1 Q2 Q3 Q4 |\n| 1 Lead optimization\u003Cbr>1.1 Research-grade synthesis \u003Cbr>1.2 In vitro characterization \u003Cbr>2 PK\u003Cbr>2.1 Bioanalytical development \u003Cbr>2.2 non-GLP PK / biodistribution\u003Cbr>2.3 Single-dose tolerability\u003Cbr>3 In vivo efficacy\u003Cbr>3.1 Functional efficacy\u003Cbr>3.2 Histopathology\u003Cbr>4 Pre-IND\u003Cbr>4.1 Package preparation & meeting\u003Cbr>5 CMC\u003Cbr>5.1 Toxicology lot\u003Cbr>5.2 GMP drug substance\u003Cbr>5.3 Stability\u003Cbr>5.4 Drug product formulation\u003Cbr>6 GLP safety pharmacology\u003Cbr>6.1 12-week rodent\u003Cbr>6.2 12-week NHP\u003Cbr>7 IND submission\u003Cbr>7.1 IND preparation & filing | \u003Cbr>\u003Cbr>| | |  |\n\nPI-led Sub-award NIH CRO","cbCaimwxFzuuGqej","https://ap.wps.com/l/cbCaimwxFzuuGqej","pdf",171146,"English","# Sample BPN Biologics Gantt Chart\n## Key Activities by Year and Phase\n### Year 1 - Phase I\n### Year 2 - Phase I\n### Year 3 - Phase II\n### Year 4 - Phase II\n### Year 5 - Phase II","[{\"question\":\"What is the purpose of the provided Gantt chart example?\",\"answer\":\"The Gantt chart example is for illustrative purposes, demonstrating the required format for BPN Biologics applications, and is not an endorsement of specific activities or plans.\"},{\"question\":\"What information must be included in a Gantt chart attached to BPN Biologics applications?\",\"answer\":\"Gantt charts must include a project timeline showing key activities for each year of grant funding and clearly indicate who will conduct each activity.\"},{\"question\":\"What are the main phases and activities detailed in the sample Gantt chart?\",\"answer\":\"The sample chart outlines Phase I and Phase II activities over five years, including lead optimization, PK studies, in vivo efficacy, pre-IND preparation, CMC, safety pharmacology, and IND submission.\"}]","Gantt-chart-example-BPN-Biologics | PDF"]